APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Multistrain Probiotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Multistrain Probiotics Market Outlook and Growth Opportunities 2026

Report ID 173313870423 December 2025195 pages

Choose your research edition.

Industry ResearchMultistrain Probiotics Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Multistrain Probiotics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Multistrain Probiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multistrain Probiotics Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Multistrain Probiotics Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Multistrain Probiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Multistrain Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multistrain Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multistrain Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Multistrain Probiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Multistrain Probiotics market include Novozymes A/S, Lallemand, Inc., Kerry Plc, IFF Inc. (International Flavors & Fragrances Inc.), DSM (Koninklijke DSM N.V.), Kaneka Corporation, Alltech, Probi AB and LeSaffre, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Multistrain Probiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multistrain Probiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multistrain Probiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Multistrain Probiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Multistrain Probiotics Segment by Company

Novozymes A/S

Lallemand, Inc.

Kerry Plc

IFF Inc. (International Flavors & Fragrances Inc.)

DSM (Koninklijke DSM N.V.)

Kaneka Corporation

Alltech

Probi AB

LeSaffre

Chr. Hansen A/S

ADM (Archer Daniels Midland Company)

CKD Bio Corporation

Multistrain Probiotics Segment by Type

Yeast

Bacteria

Multistrain Probiotics Segment by Application

Animal Feed

Personal Care and Cosmetics

Dietary Supplements

Food and Beverages

Other

Multistrain Probiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Multistrain Probiotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Multistrain Probiotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Multistrain Probiotics significant trends, drivers, influence factors in global and regions.

6. To analyze Multistrain Probiotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multistrain Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multistrain Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multistrain Probiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Multistrain Probiotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multistrain Probiotics industry.

Chapter 3: Detailed analysis of Multistrain Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Multistrain Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Multistrain Probiotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Multistrain Probiotics Industry Trends Table 2. Multistrain Probiotics Industry Drivers Table 3. Multistrain Probiotics Industry Opportunities and Challenges Table 4. Multistrain Probiotics Industry Restraints Table 5. Global Multistrain Probiotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Multistrain Probiotics Revenue Share by Company (2021-2026) Table 7. Global Multistrain Probiotics Sales Volume by Company (K Ton) & (2021-2026) Table 8. Global Multistrain Probiotics Sales Volume Share by Company (2021-2026) Table 9. Global Multistrain Probiotics Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Multistrain Probiotics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Multistrain Probiotics Key Company Manufacturing Base & Headquarters Table 12. Global Multistrain Probiotics Company, Product Type & Application Table 13. Global Multistrain Probiotics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Multistrain Probiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Yeast Table 18. Significant Companies of Bacteria Table 19. Global Multistrain Probiotics Sales Volume by Type 2021 VS 2025 VS 2032 (K Ton) Table 20. Global Multistrain Probiotics Sales Volume by Type (2021-2026) & (K Ton) Table 21. Global Multistrain Probiotics Sales Volume by Type (2027-2032) & (K Ton) Table 22. Global Multistrain Probiotics Sales Volume Share by Type (2021-2026) Table 23. Global Multistrain Probiotics Sales Volume Share by Type (2027-2032) Table 24. Global Multistrain Probiotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Multistrain Probiotics Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Multistrain Probiotics Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Multistrain Probiotics Sales Value Share by Type (2021-2026) Table 28. Global Multistrain Probiotics Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Animal Feed Table 30. Significant Companies of Personal Care and Cosmetics Table 31. Significant Companies of Dietary Supplements Table 32. Significant Companies of Food and Beverages Table 33. Significant Companies of Other Table 34. Global Multistrain Probiotics Sales Volume by Application 2021 VS 2025 VS 2032 (K Ton) Table 35. Global Multistrain Probiotics Sales Volume by Application (2021-2026) & (K Ton) Table 36. Global Multistrain Probiotics Sales Volume by Application (2027-2032) & (K Ton) Table 37. Global Multistrain Probiotics Sales Volume Share by Application (2021-2026) Table 38. Global Multistrain Probiotics Sales Volume Share by Application (2027-2032) Table 39. Global Multistrain Probiotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Multistrain Probiotics Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Multistrain Probiotics Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Multistrain Probiotics Sales Value Share by Application (2021-2026) Table 43. Global Multistrain Probiotics Sales Value Share by Application (2027-2032) Table 44. Global Multistrain Probiotics Sales by Region: 2021 VS 2025 VS 2032 (K Ton) Table 45. Global Multistrain Probiotics Sales by Region (2021-2026) & (K Ton) Table 46. Global Multistrain Probiotics Sales Market Share by Region (2021-2026) Table 47. Global Multistrain Probiotics Sales by Region (2027-2032) & (K Ton) Table 48. Global Multistrain Probiotics Sales Market Share by Region (2027-2032) Table 49. Global Multistrain Probiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Multistrain Probiotics Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Multistrain Probiotics Sales Value Share by Region (2021-2026) Table 52. Global Multistrain Probiotics Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Multistrain Probiotics Sales Value Share by Region (2027-2032) Table 54. Global Multistrain Probiotics Market Average Price (US$/Ton) by Region (2021-2026) Table 55. Global Multistrain Probiotics Market Average Price (US$/Ton) by Region (2027-2032) Table 56. Global Multistrain Probiotics Sales by Country: 2021 VS 2025 VS 2032 (K Ton) Table 57. Global Multistrain Probiotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Multistrain Probiotics Sales by Country (2021-2026) & (K Ton) Table 59. Global Multistrain Probiotics Sales Market Share by Country (2021-2026) Table 60. Global Multistrain Probiotics Sales by Country (2027-2032) & (K Ton) Table 61. Global Multistrain Probiotics Sales Market Share by Country (2027-2032) Table 62. Global Multistrain Probiotics Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Multistrain Probiotics Sales Value Market Share by Country (2021-2026) Table 64. Global Multistrain Probiotics Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Multistrain Probiotics Sales Value Market Share by Country (2027-2032) Table 66. Novozymes A/S Company Information Table 67. Novozymes A/S Business Overview Table 68. Novozymes A/S Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Novozymes A/S Multistrain Probiotics Product Portfolio Table 70. Novozymes A/S Recent Development Table 71. Lallemand, Inc. Company Information Table 72. Lallemand, Inc. Business Overview Table 73. Lallemand, Inc. Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Lallemand, Inc. Multistrain Probiotics Product Portfolio Table 75. Lallemand, Inc. Recent Development Table 76. Kerry Plc Company Information Table 77. Kerry Plc Business Overview Table 78. Kerry Plc Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Kerry Plc Multistrain Probiotics Product Portfolio Table 80. Kerry Plc Recent Development Table 81. IFF Inc. (International Flavors & Fragrances Inc.) Company Information Table 82. IFF Inc. (International Flavors & Fragrances Inc.) Business Overview Table 83. IFF Inc. (International Flavors & Fragrances Inc.) Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. IFF Inc. (International Flavors & Fragrances Inc.) Multistrain Probiotics Product Portfolio Table 85. IFF Inc. (International Flavors & Fragrances Inc.) Recent Development Table 86. DSM (Koninklijke DSM N.V.) Company Information Table 87. DSM (Koninklijke DSM N.V.) Business Overview Table 88. DSM (Koninklijke DSM N.V.) Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. DSM (Koninklijke DSM N.V.) Multistrain Probiotics Product Portfolio Table 90. DSM (Koninklijke DSM N.V.) Recent Development Table 91. Kaneka Corporation Company Information Table 92. Kaneka Corporation Business Overview Table 93. Kaneka Corporation Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Kaneka Corporation Multistrain Probiotics Product Portfolio Table 95. Kaneka Corporation Recent Development Table 96. Alltech Company Information Table 97. Alltech Business Overview Table 98. Alltech Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Alltech Multistrain Probiotics Product Portfolio Table 100. Alltech Recent Development Table 101. Probi AB Company Information Table 102. Probi AB Business Overview Table 103. Probi AB Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Probi AB Multistrain Probiotics Product Portfolio Table 105. Probi AB Recent Development Table 106. LeSaffre Company Information Table 107. LeSaffre Business Overview Table 108. LeSaffre Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. LeSaffre Multistrain Probiotics Product Portfolio Table 110. LeSaffre Recent Development Table 111. Chr. Hansen A/S Company Information Table 112. Chr. Hansen A/S Business Overview Table 113. Chr. Hansen A/S Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Chr. Hansen A/S Multistrain Probiotics Product Portfolio Table 115. Chr. Hansen A/S Recent Development Table 116. ADM (Archer Daniels Midland Company) Company Information Table 117. ADM (Archer Daniels Midland Company) Business Overview Table 118. ADM (Archer Daniels Midland Company) Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. ADM (Archer Daniels Midland Company) Multistrain Probiotics Product Portfolio Table 120. ADM (Archer Daniels Midland Company) Recent Development Table 121. CKD Bio Corporation Company Information Table 122. CKD Bio Corporation Business Overview Table 123. CKD Bio Corporation Multistrain Probiotics Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. CKD Bio Corporation Multistrain Probiotics Product Portfolio Table 125. CKD Bio Corporation Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Multistrain Probiotics Distributors List Table 129. Multistrain Probiotics Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Multistrain Probiotics Product Image Figure 2. Global Multistrain Probiotics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multistrain Probiotics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Multistrain Probiotics Sales (2021-2032) & (K Ton) Figure 5. Global Multistrain Probiotics Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Multistrain Probiotics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Yeast Image Figure 10. Bacteria Image Figure 11. Global Multistrain Probiotics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Ton) Figure 12. Global Multistrain Probiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Multistrain Probiotics Sales Volume Share by Type (2021-2032) Figure 14. Global Multistrain Probiotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Multistrain Probiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Multistrain Probiotics Sales Value Share by Type (2021-2032) Figure 17. Animal Feed Image Figure 18. Personal Care and Cosmetics Image Figure 19. Dietary Supplements Image Figure 20. Food and Beverages Image Figure 21. Other Image Figure 22. Global Multistrain Probiotics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Ton) Figure 23. Global Multistrain Probiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Multistrain Probiotics Sales Volume Share by Application (2021-2032) Figure 25. Global Multistrain Probiotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Multistrain Probiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Multistrain Probiotics Sales Value Share by Application (2021-2032) Figure 28. Global Multistrain Probiotics Sales by Region: 2021 VS 2025 VS 2032 (K Ton) Figure 29. Global Multistrain Probiotics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Multistrain Probiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Multistrain Probiotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Multistrain Probiotics Sales Value (2021-2032) & (US$ Million) Figure 33. North America Multistrain Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Multistrain Probiotics Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Multistrain Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Multistrain Probiotics Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Multistrain Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Multistrain Probiotics Sales Value (2021-2032) & (US$ Million) Figure 39. South America Multistrain Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Multistrain Probiotics Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Multistrain Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Multistrain Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Multistrain Probiotics Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Multistrain Probiotics Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast
  • Bacteria
Applications
  • Animal Feed
  • Personal Care and Cosmetics
  • Dietary Supplements
  • Food and Beverages
  • Other
Companies covered
  • Novozymes A/S
  • Lallemand, Inc.
  • Kerry Plc
  • IFF Inc. (International Flavors & Fragrances Inc.)
  • DSM (Koninklijke DSM N.V.)
  • Kaneka Corporation
  • Alltech
  • Probi AB
  • LeSaffre
  • Chr. Hansen A/S
  • ADM (Archer Daniels Midland Company)
  • CKD Bio Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Multistrain Probiotics Sales Value (2021-2032)
  4. 1.2.2 Global Multistrain Probiotics Sales Volume (2021-2032)
  5. 1.2.3 Global Multistrain Probiotics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Multistrain Probiotics Market Dynamics
  1. 2.1 Multistrain Probiotics Industry Trends
  2. 2.2 Multistrain Probiotics Industry Drivers
  3. 2.3 Multistrain Probiotics Industry Opportunities and Challenges
  4. 2.4 Multistrain Probiotics Industry Restraints
3 Multistrain Probiotics Market by Company
  1. 3.1 Global Multistrain Probiotics Company Revenue Ranking in 2025
  2. 3.2 Global Multistrain Probiotics Revenue by Company (2021-2026)
  3. 3.3 Global Multistrain Probiotics Sales Volume by Company (2021-2026)
  4. 3.4 Global Multistrain Probiotics Average Price by Company (2021-2026)
  5. 3.5 Global Multistrain Probiotics Company Ranking (2024-2026)
  6. 3.6 Global Multistrain Probiotics Company Manufacturing Base and Headquarters
  7. 3.7 Global Multistrain Probiotics Company Product Type and Application
  8. 3.8 Global Multistrain Probiotics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Multistrain Probiotics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Multistrain Probiotics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Multistrain Probiotics Market by Type
  1. 4.1 Multistrain Probiotics Type Introduction
  2. 4.1.1 Yeast
  3. 4.1.2 Bacteria
  4. 4.2 Global Multistrain Probiotics Sales Volume by Type
  5. 4.2.1 Global Multistrain Probiotics Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Multistrain Probiotics Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Multistrain Probiotics Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Multistrain Probiotics Sales Value by Type
  9. 4.3.1 Global Multistrain Probiotics Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Multistrain Probiotics Sales Value by Type (2021-2032)
  11. 4.3.3 Global Multistrain Probiotics Sales Value Share by Type (2021-2032)
5 Multistrain Probiotics Market by Application
  1. 5.1 Multistrain Probiotics Application Introduction
  2. 5.1.1 Animal Feed
  3. 5.1.2 Personal Care and Cosmetics
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Food and Beverages
  6. 5.1.5 Other
  7. 5.2 Global Multistrain Probiotics Sales Volume by Application
  8. 5.2.1 Global Multistrain Probiotics Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Multistrain Probiotics Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Multistrain Probiotics Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Multistrain Probiotics Sales Value by Application
  12. 5.3.1 Global Multistrain Probiotics Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Multistrain Probiotics Sales Value by Application (2021-2032)
  14. 5.3.3 Global Multistrain Probiotics Sales Value Share by Application (2021-2032)
6 Multistrain Probiotics Regional Sales and Value Analysis
  1. 6.1 Global Multistrain Probiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Multistrain Probiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Multistrain Probiotics Sales by Region: 2021-2026
  4. 6.2.2 Global Multistrain Probiotics Sales by Region (2027-2032)
  5. 6.3 Global Multistrain Probiotics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Multistrain Probiotics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Multistrain Probiotics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Multistrain Probiotics Sales Value by Region (2027-2032)
  9. 6.5 Global Multistrain Probiotics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Multistrain Probiotics Sales Value (2021-2032)
  12. 6.6.2 North America Multistrain Probiotics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Multistrain Probiotics Sales Value (2021-2032)
  15. 6.7.2 Europe Multistrain Probiotics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Multistrain Probiotics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Multistrain Probiotics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Multistrain Probiotics Sales Value (2021-2032)
  21. 6.9.2 South America Multistrain Probiotics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Multistrain Probiotics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Multistrain Probiotics Sales Value Share by Country, 2025 VS 2032
7 Multistrain Probiotics Country-level Sales and Value Analysis
  1. 7.1 Global Multistrain Probiotics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Multistrain Probiotics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Multistrain Probiotics Sales by Country (2021-2032)
  4. 7.3.1 Global Multistrain Probiotics Sales by Country (2021-2026)
  5. 7.3.2 Global Multistrain Probiotics Sales by Country (2027-2032)
  6. 7.4 Global Multistrain Probiotics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Multistrain Probiotics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Multistrain Probiotics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Multistrain Probiotics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Multistrain Probiotics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Multistrain Probiotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novozymes A/S
  2. 8.1.1 Novozymes A/S Company Information
  3. 8.1.2 Novozymes A/S Business Overview
  4. 8.1.3 Novozymes A/S Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novozymes A/S Multistrain Probiotics Product Portfolio
  6. 8.1.5 Novozymes A/S Recent Developments
  7. 8.2 Lallemand, Inc.
  8. 8.2.1 Lallemand, Inc. Company Information
  9. 8.2.2 Lallemand, Inc. Business Overview
  10. 8.2.3 Lallemand, Inc. Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lallemand, Inc. Multistrain Probiotics Product Portfolio
  12. 8.2.5 Lallemand, Inc. Recent Developments
  13. 8.3 Kerry Plc
  14. 8.3.1 Kerry Plc Company Information
  15. 8.3.2 Kerry Plc Business Overview
  16. 8.3.3 Kerry Plc Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kerry Plc Multistrain Probiotics Product Portfolio
  18. 8.3.5 Kerry Plc Recent Developments
  19. 8.4 IFF Inc. (International Flavors & Fragrances Inc.)
  20. 8.4.1 IFF Inc. (International Flavors & Fragrances Inc.) Company Information
  21. 8.4.2 IFF Inc. (International Flavors & Fragrances Inc.) Business Overview
  22. 8.4.3 IFF Inc. (International Flavors & Fragrances Inc.) Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 IFF Inc. (International Flavors & Fragrances Inc.) Multistrain Probiotics Product Portfolio
  24. 8.4.5 IFF Inc. (International Flavors & Fragrances Inc.) Recent Developments
  25. 8.5 DSM (Koninklijke DSM N.V.)
  26. 8.5.1 DSM (Koninklijke DSM N.V.) Company Information
  27. 8.5.2 DSM (Koninklijke DSM N.V.) Business Overview
  28. 8.5.3 DSM (Koninklijke DSM N.V.) Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DSM (Koninklijke DSM N.V.) Multistrain Probiotics Product Portfolio
  30. 8.5.5 DSM (Koninklijke DSM N.V.) Recent Developments
  31. 8.6 Kaneka Corporation
  32. 8.6.1 Kaneka Corporation Company Information
  33. 8.6.2 Kaneka Corporation Business Overview
  34. 8.6.3 Kaneka Corporation Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kaneka Corporation Multistrain Probiotics Product Portfolio
  36. 8.6.5 Kaneka Corporation Recent Developments
  37. 8.7 Alltech
  38. 8.7.1 Alltech Company Information
  39. 8.7.2 Alltech Business Overview
  40. 8.7.3 Alltech Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Alltech Multistrain Probiotics Product Portfolio
  42. 8.7.5 Alltech Recent Developments
  43. 8.8 Probi AB
  44. 8.8.1 Probi AB Company Information
  45. 8.8.2 Probi AB Business Overview
  46. 8.8.3 Probi AB Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Probi AB Multistrain Probiotics Product Portfolio
  48. 8.8.5 Probi AB Recent Developments
  49. 8.9 LeSaffre
  50. 8.9.1 LeSaffre Company Information
  51. 8.9.2 LeSaffre Business Overview
  52. 8.9.3 LeSaffre Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 LeSaffre Multistrain Probiotics Product Portfolio
  54. 8.9.5 LeSaffre Recent Developments
  55. 8.10 Chr. Hansen A/S
  56. 8.10.1 Chr. Hansen A/S Company Information
  57. 8.10.2 Chr. Hansen A/S Business Overview
  58. 8.10.3 Chr. Hansen A/S Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Chr. Hansen A/S Multistrain Probiotics Product Portfolio
  60. 8.10.5 Chr. Hansen A/S Recent Developments
  61. 8.11 ADM (Archer Daniels Midland Company)
  62. 8.11.1 ADM (Archer Daniels Midland Company) Company Information
  63. 8.11.2 ADM (Archer Daniels Midland Company) Business Overview
  64. 8.11.3 ADM (Archer Daniels Midland Company) Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ADM (Archer Daniels Midland Company) Multistrain Probiotics Product Portfolio
  66. 8.11.5 ADM (Archer Daniels Midland Company) Recent Developments
  67. 8.12 CKD Bio Corporation
  68. 8.12.1 CKD Bio Corporation Company Information
  69. 8.12.2 CKD Bio Corporation Business Overview
  70. 8.12.3 CKD Bio Corporation Multistrain Probiotics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CKD Bio Corporation Multistrain Probiotics Product Portfolio
  72. 8.12.5 CKD Bio Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Multistrain Probiotics Value Chain Analysis
  2. 9.1.1 Multistrain Probiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Multistrain Probiotics Sales Mode & Process
  6. 9.2 Multistrain Probiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Multistrain Probiotics Distributors
  9. 9.2.3 Multistrain Probiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst